New drug immunoglobulin could give three-year reprieve from Alzheimer's

Substance made from antibodies in human blood could be on the shelves in 10 years

Scientists have hailed a new drug for Alzheimer's disease after a trial successfully halted the mental decline associated with the condition for a period of three years.

Researchers found that patients who had injections every two weeks of the drug immunoglobulin, made from antibodies in human blood, showed no decline in cognition, memory, daily functioning or mood.

Immunoglobulin is normally given to patients who suffer from an immune deficiency, but it has also been found to protect the brains of those with early stage Alzheimer's. Each dose is extracted from the plasma of 1,000 blood donors.

Professor Clive Ballard, director of research at the Alzheimer's Society, said: "This is probably the most exciting drug we know about that is currently in the late stages of research.

"We now know it is safe but the real test will be whether these initial promising results can subsequently be replicated in larger groups."

Just 24 patients were tested with the drug in the study, who were given varying doses of the drug over different periods. A larger study is now underway. Professor Ballard added: "If the phase 3 trials are successful, and it can be made cost effective, this drug could be on the shelves within 10 years."

He added: "One in three people over 65 will develop dementia. While finding a cure is the Holy Grail of dementia research, it is also vitally important that we continue to fund studies like this if we are to develop more treatments to help people to live well with the condition."

However, the difficulty of producing immunoglobulin means it is not cheap, costing thousands of pounds per patient. The findings were presented at the Alzheimer's Association International Conference in Vancouver, Canada, yesterday.

There are currently three licensed drugs for the prevention of Alzheimers in the early and moderate stages but they are of limited effectiveness, slowing the progression of the disease in some patients but not in others.

Researchers studying immunoglobulin had previously reported its beneficial effects up to 18 months but have now extended the treatment for a further 18 months and found no decline in cognition and memory.

Scientists have been experimenting with immunotherapy – treatments to stimulate the immune system in Alzheimers patients – for several years but this is the first that has been shown to be both effective and safe.

The drug is thought to work by targeting the beta-amyloid protein, sweeping up and removing small fragments that form the amyloid plaques in the brain that lie behind the degenerative disease.

Normal Relkin, of Weill Cornell Medical College, New York, said: "This is the first study to report long-term stabilisation of Alzheimer's symptoms with intravenous immunoglobulin. While the small number of participants may limit the reliability of our findings , we are very enthusiastic about the results."

Early findings from the trial showed rates of brain shrinkage typical of Alzheimer's were halved in patients treated with the drug, as measured on MRI scans.

Life and Style
ebookNow available in paperback
ebooks
ebookA delicious collection of 50 meaty main courses
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
SPONSORED FEATURES

ES Rentals

    Independent Dating
    and  

    By clicking 'Search' you
    are agreeing to our
    Terms of Use.

    iJobs Job Widget
    iJobs General

    Recruitment Genius: Personal Tax Senior

    £28000 - £37000 per annum: Recruitment Genius: This is an opportunity to join ...

    Recruitment Genius: Customer and Markets Development Executive

    £22000 - £29000 per annum: Recruitment Genius: This company's mission is to ma...

    Recruitment Genius: Guest Services Assistant

    £13832 per annum: Recruitment Genius: This 5 star leisure destination on the w...

    Recruitment Genius: Sales Account Manager

    £20000 - £32000 per annum: Recruitment Genius: A Sales Account Manager is requ...

    Day In a Page

    A nap a day could save your life - and here's why

    A nap a day could save your life

    A midday nap is 'associated with reduced blood pressure'
    If men are so obsessed by sex, why do they clam up when confronted with the grisly realities?

    If men are so obsessed by sex...

    ...why do they clam up when confronted with the grisly realities?
    The comedy titans of Avalon on their attempt to save BBC3

    Jon Thoday and Richard Allen-Turner

    The comedy titans of Avalon on their attempt to save BBC3
    The bathing machine is back... but with a difference

    Rolling in the deep

    The bathing machine is back but with a difference
    Part-privatised tests, new age limits, driverless cars: Tories plot motoring revolution

    Conservatives plot a motoring revolution

    Draft report reveals biggest reform to regulations since driving test introduced in 1935
    The Silk Roads that trace civilisation: Long before the West rose to power, Asian pathways were connecting peoples and places

    The Silk Roads that trace civilisation

    Long before the West rose to power, Asian pathways were connecting peoples and places
    House of Lords: Outcry as donors, fixers and MPs caught up in expenses scandal are ennobled

    The honours that shame Britain

    Outcry as donors, fixers and MPs caught up in expenses scandal are ennobled
    When it comes to street harassment, we need to talk about race

    'When it comes to street harassment, we need to talk about race'

    Why are black men living the stereotypes and why are we letting them get away with it?
    International Tap Festival: Forget Fred Astaire and Ginger Rogers - this dancing is improvised, spontaneous and rhythmic

    International Tap Festival comes to the UK

    Forget Fred Astaire and Ginger Rogers - this dancing is improvised, spontaneous and rhythmic
    War with Isis: Is Turkey's buffer zone in Syria a matter of self-defence – or just anti-Kurd?

    Turkey's buffer zone in Syria: self-defence – or just anti-Kurd?

    Ankara accused of exacerbating racial division by allowing Turkmen minority to cross the border
    Doris Lessing: Acclaimed novelist was kept under MI5 observation for 18 years, newly released papers show

    'A subversive brothel keeper and Communist'

    Acclaimed novelist Doris Lessing was kept under MI5 observation for 18 years, newly released papers show
    Big Blue Live: BBC's Springwatch offshoot swaps back gardens for California's Monterey Bay

    BBC heads to the Californian coast

    The Big Blue Live crew is preparing for the first of three episodes on Sunday night, filming from boats, planes and an aquarium studio
    Austin Bidwell: The Victorian fraudster who shook the Bank of England with the most daring forgery the world had known

    Victorian fraudster who shook the Bank of England

    Conman Austin Bidwell. was a heartless cad who carried out the most daring forgery the world had known
    Car hacking scandal: Security designed to stop thieves hot-wiring almost every modern motor has been cracked

    Car hacking scandal

    Security designed to stop thieves hot-wiring almost every modern motor has been cracked
    10 best placemats

    Take your seat: 10 best placemats

    Protect your table and dine in style with a bold new accessory